Systematic Financial Management LP Gilead Sciences, Inc. Transaction History

Systematic Financial Management LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2018 Aug 08, 2018	SELL	$64.88 - $75.68 $1.86 Million - $2.17 Million	-28,726 Closed	0 $0
Q1 2018 May 09, 2018	SELL	$72.84 - $88.8 $2,913 - $3,552	-40 Reduced 0.14%	28,726 $2.17 Million
Q4 2017 Feb 09, 2018	BUY	$71.15 - $83.52 $987,917 - $1.16 Million	13,885 Added 93.31%	28,766 $2.06 Million
Q3 2017 Nov 08, 2017	BUY	$72.11 - $85.47 $1.07 Million - $1.27 Million	14,881	14,881 $1.21 Million

1,927

994M

10.5M

9.75M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $116B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Systematic Financial Management LP, based on Form 13F filings with the SEC.

Stay updated on Systematic Financial Management LP with notifications on news.